Aron Chakera

1.9k total citations
84 papers, 959 citations indexed

About

Aron Chakera is a scholar working on Nephrology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Aron Chakera has authored 84 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Nephrology, 19 papers in Epidemiology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Aron Chakera's work include Dialysis and Renal Disease Management (16 papers), Renal Diseases and Glomerulopathies (16 papers) and Chronic Kidney Disease and Diabetes (14 papers). Aron Chakera is often cited by papers focused on Dialysis and Renal Disease Management (16 papers), Renal Diseases and Glomerulopathies (16 papers) and Chronic Kidney Disease and Diabetes (14 papers). Aron Chakera collaborates with scholars based in Australia, United Kingdom and New Zealand. Aron Chakera's co-authors include Sophia Bennett, Christopher A. O’Callaghan, Richard J. Cornall, Olivier Morteau, Shubha S. Bellur, Wai H. Lim, Clare MacEwen, S. A. Roberts, Alison E. John and Ruth M. Seeber and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemistry.

In The Last Decade

Aron Chakera

79 papers receiving 950 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aron Chakera Australia 18 222 215 202 161 136 84 959
Josef Zadražil Czechia 17 327 1.5× 203 0.9× 102 0.5× 88 0.5× 130 1.0× 88 983
In O Sun South Korea 19 331 1.5× 131 0.6× 102 0.5× 105 0.7× 228 1.7× 75 969
T. Ben Abdallah Tunisia 16 139 0.6× 192 0.9× 78 0.4× 246 1.5× 104 0.8× 198 1.0k
Kuo‐Hsiung Shu Taiwan 21 296 1.3× 85 0.4× 193 1.0× 200 1.2× 178 1.3× 75 1.3k
Roman Reindl‐Schwaighofer Austria 19 160 0.7× 159 0.7× 81 0.4× 145 0.9× 106 0.8× 54 885
Lutz Renders Germany 22 358 1.6× 134 0.6× 188 0.9× 200 1.2× 204 1.5× 94 1.5k
E. Abderrahim Tunisia 15 143 0.6× 97 0.5× 70 0.3× 132 0.8× 75 0.6× 135 802
Rachel Hilton United Kingdom 18 142 0.6× 182 0.8× 181 0.9× 101 0.6× 33 0.2× 52 793
Paolo Malvezzi France 19 147 0.7× 168 0.8× 128 0.6× 219 1.4× 100 0.7× 93 1.1k
Jan Goßmann Germany 20 153 0.7× 127 0.6× 387 1.9× 194 1.2× 109 0.8× 42 1.4k

Countries citing papers authored by Aron Chakera

Since Specialization
Citations

This map shows the geographic impact of Aron Chakera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aron Chakera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aron Chakera more than expected).

Fields of papers citing papers by Aron Chakera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aron Chakera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aron Chakera. The network helps show where Aron Chakera may publish in the future.

Co-authorship network of co-authors of Aron Chakera

This figure shows the co-authorship network connecting the top 25 collaborators of Aron Chakera. A scholar is included among the top collaborators of Aron Chakera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aron Chakera. Aron Chakera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chakera, Aron, et al.. (2025). Incorporating the Clinical Frailty Scale into routine outpatient nephrology practice: a 3‐year follow‐up of outcomes and associations. Internal Medicine Journal. 55(5). 839–845. 1 indexed citations
2.
Mehta, Kanika, Sean Randall, Crystal Lee, et al.. (2025). Prevalence of chronic kidney disease in Western Australia, 2010–2020. BMJ Open. 15(1). e092320–e092320. 2 indexed citations
3.
Randall, Sean, Crystal Lee, Elizabeth Thomas, et al.. (2024). Estimating the cost of chronic kidney disease in Australia. BMC Health Services Research. 24(1). 1468–1468.
4.
López, Pedro, Nicholas Larkins, Aron Chakera, et al.. (2024). Clinical Applicability of 2‐Field High‐Resolution and Extended HLA‐Allele Typing in Deceased Donor Kidney Allocation. HLA. 104(6). 1 indexed citations
5.
6.
Morey, Sue, et al.. (2023). Topical antibiotics prophylaxis for infections of indwelling pleural/peritoneal catheters (TAP‐IPC): A pilot study. Respirology. 29(2). 176–182. 1 indexed citations
7.
Chan, Doris, et al.. (2023). Patient and nursing experience of flash glucose monitoring following kidney transplantation. Nephrology. 28(9). 510–514. 1 indexed citations
8.
Chakera, Aron, et al.. (2022). Antibiotic administration via indwelling peritoneal catheter to treat infected malignant ascites. SHILAP Revista de lepidopterología. 10(11). e01055–e01055. 1 indexed citations
9.
Boyd, James, Elizabeth Thomas, Aron Chakera, et al.. (2022). Prediction models used in the progression of chronic kidney disease: A scoping review. PLoS ONE. 17(7). e0271619–e0271619. 15 indexed citations
10.
Carson, Christine, et al.. (2022). Same-day confirmation of infection and antimicrobial susceptibility profiling using flow cytometry. EBioMedicine. 82. 104145–104145. 10 indexed citations
11.
Chakera, Aron, et al.. (2020). Incorporating the Clinical Frailty Scale into routine outpatient nephrology practice: an observational study of feasibility and associations. Internal Medicine Journal. 51(8). 1269–1277. 8 indexed citations
12.
Lam, Wei‐Sen, Jenette Creaney, Fred K. Chen, et al.. (2019). A phase II trial of single oral FGF inhibitor, AZD4547, as second or third line therapy in malignant pleural mesothelioma. Lung Cancer. 140. 87–92. 27 indexed citations
13.
Nossent, Johannes C., et al.. (2019). The importance of tubuloreticular inclusion bodies in lupus nephritis. International Journal of Rheumatic Diseases. 22. 1 indexed citations
14.
Jayasinghe, Kushani, Zornitza Stark, Chirag Patel, et al.. (2019). Comprehensive evaluation of a prospective Australian patient cohort with suspected genetic kidney disease undergoing clinical genomic testing: a study protocol. BMJ Open. 9(8). e029541–e029541. 12 indexed citations
15.
Irish, Ashley, Lloyd D’Orsogna, Aron Chakera, et al.. (2019). Allograft and Patient Outcomes Between Indigenous and Nonindigenous Kidney Transplant Recipients. Transplantation. 104(4). 847–855. 6 indexed citations
16.
Nossent, Johannes C., et al.. (2018). The role for renal histology as predictor for outcome in lupus nephritis in Western Australia. International Journal of Rheumatic Diseases. 21.
17.
Lim, Wai H., Germaine Wong, Stephen P. McDonald, et al.. (2018). Long-term outcomes of kidney transplant recipients with end-stage kidney disease attributed to presumed/advanced glomerulonephritis or unknown cause. Scientific Reports. 8(1). 9021–9021. 9 indexed citations
18.
Chakera, Aron, et al.. (2017). With a little help from my friends: Developing an assisted automated peritoneal dialysis program in Western Australia. eSpace (Curtin University). 13(3). 83–89. 2 indexed citations
19.
Lansley, Sally M., et al.. (2014). Tissue Plasminogen Activator Potently Stimulates Pleural Effusion via a Monocyte Chemotactic Protein-1–Dependent Mechanism. American Journal of Respiratory Cell and Molecular Biology. 53(1). 105–112. 33 indexed citations
20.
Chakera, Aron, Sophia Bennett, & Richard J. Cornall. (2011). A whole blood monokine-based reporter assay provides a sensitive and robust measurement of the antigen-specific T cell response. Journal of Translational Medicine. 9(1). 143–143. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Josef Zadražil Breakdown of academic impact, for papers by In O Sun Breakdown of academic impact, for papers by T. Ben Abdallah Breakdown of academic impact, for papers by Kuo‐Hsiung Shu Breakdown of academic impact, for papers by Roman Reindl‐Schwaighofer Breakdown of academic impact, for papers by Lutz Renders Breakdown of academic impact, for papers by E. Abderrahim Breakdown of academic impact, for papers by Rachel Hilton Breakdown of academic impact, for papers by Paolo Malvezzi Breakdown of academic impact, for papers by Jan Goßmann
Rankless by CCL
2026